Motesanib diphosphate in progressive differentiated thyroid cancer.
Diaz-Cano
Salvador J
SJ
D018263:Adenocarcinoma, Follicular / Q000188:drug therapy* / Q000473:pathology; D014408:Biomarkers, Tumor; D018450:Disease Progression; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009841:Oligonucleotides; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology
D014408:Biomarkers, Tumor; D007211:Indoles; D009841:Oligonucleotides; D009536:Niacinamide; D020928:Mitogen-Activated Protein Kinases; C519562:imetelstat